Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer - Related Studies

Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003342. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bladder Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Transitional Cell
		Kidney Neoplasms
		Ureteral Neoplasms
		Urinary Bladder Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Kidney Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Ureteral Diseases
		Urinary Bladder Diseases
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		carboplatin
		doxorubicin hydrochloride
		filgrastim
		gemcitabine hydrochloride
		paclitaxel

5	Additional drug interventions recognized in this trial
		Doxorubicin
		Gemcitabine

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Antiviral Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Memorial Sloan-Kettering Cancer Center
		National Cancer Institute (NCI)